⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 23, 2026

Ibuprofen B. Braun 400 mg Infusionslösung 400 mg (Infusionslösung)

📷 Wikipedia: Ibuprofen · Source
Ibuprofen B. Braun 400 mg Infusionslösung 400 mg (Infusionslösung)
📷 Wikipedia: Ibuprofen · Source
Parallel export ban in effect.
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 34 days ago.
📈 Timeline
3 days in total
May 18, 2026 May 21, 2026

What is this? This is a liquid medicine called Ibuprofen B. Braun. It is given through a drip into a vein. It helps with pain and swelling.

What's happening? The medicine is not available right now. It will be back in stock on May 22.

Does this affect me? If you need this medicine now, you may not be able to get it.

What should I do? Ask your pharmacist or doctor for advice. They can suggest another medicine for you.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
IBUPROFEN
Agency-published detail

🚫 Parallel export ban active · ATC: M01AE01 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: B. Braun Melsungen AG, Carl-Braun-Straße 1, 34212 Melsungen, Federal Republic of Germany · Affected packs: 10 Stück Schachtel, Flasche [Nicht verfügbar, since 2026-04-13, resupply 2026-05-22]

First published
April 23, 2026
Last refreshed by us
6 days ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

Medium AT 3 months ago

Ibuprofen Kabi 400 mg Infusionslösung 4 mg/ml (Infusionslösung)

Parallel export ban in effect. Supply delayed due to manufacturing issues. Affected packs are limited.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Ibuprofen B. Braun 400 mg Infusionslösung 400 mg (Infusionslösung). Parallel export ban in effect.
▸ When was this alert issued?
This alert was issued on April 23, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.